Vascular prostheses with controlled release of antibiotics. Part 2. In vitro biological evaluation of vascular prostheses treated by cyclodextrins

Biomolecular Engineering

Volumn 24, Issue 1 SPEC. ISS., 2007, Pages 143-148

  Blanchemain, N ^a,c   Haulon, S ^a,b   Boschin, F ^a,c   Traisnel, M ^d   Morcellet, M ^c   Martel, B ^c   Hildebrand, H F ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CNRS   (France)

^d Ecole Nationale Superieure de Chimie de Lille   (France)

Author keywords

Adhesion; Biocompatibility; Cyclodextrins; Grafting; PET vascular prosthesis; Toxicity

Indexed keywords

ANTIBIOTICS; BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; POLYETHYLENE TEREPHTHALATES; POLYSACCHARIDES; TOXICITY;

CELL ADHESION; CYCLODEXTRINS; IMMUNOCHEMISTRY; PET VASCULAR PROSTHESIS;

PROSTHETICS;

ANTIBIOTIC AGENT; BETA CYCLODEXTRIN; CYCLODEXTRIN; GAMMA CYCLODEXTRIN;

ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CELL ADHESION; CELL COUNT; CELL KINETICS; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; OBSTRUCTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STENOSIS; SURVIVAL RATE;

EID: 33846879001     PISSN: 13890344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bioeng.2006.05.011     Document Type: Article

References (15)

1. Blanchemain N., Haulon S., Martel B., Traisnel M., Morcellet M., and Hildebrand H.F. Eur. J. Vasc. Endovasc. Surg. 29 (2005) 628
2. Bellringer M.E., Smith T.G., Read R., Gopinath C., and Olivier P. Food Chem. Toxicol. 33 (1995) 367
3. Brewster M.E., Estes K.S., and Bodor N. Int. J. Pharm. 39 (1990) 231
4. Donaubauer H.H., Fuchs H., Langer K.H., and Bär A. Regul. Toxicol. Pharm. 27 (1998) 189
5. Frazier, M.E., Andrews, T.K., 1979. Trace metals in health and disease. in: Kharasch, N. (Ed.). Raven Press, New York, p. 71.
6. Haulon S., Devos P., Willoteaux S., Mounier-Vehier C., Sokoloff A., Halna P., Beregi J.P., and Koussa M. Eur. J. Vasc. Endovasc. Surg. 25 (2003) 118
7. Hornez J.C., Lefèvre A., Joly D., and Hildebrand H.F. Biomol. Eng. 19 (2002) 103
8. Linez-Bataillon P., Monchau F., Bigerelle M., and Hildebrand H.F. Biomol. Eng. 19 (2002) 133
9. Martel, B., Blanchemain, N., Morcellet, M., Hildebrand, H.F., Haulon, S., Boschin, F., Delcourt-Debruyne, E., 2006. Patent application FR/04 12086.
10. Martel B., Ruffin D., Weltrowski M., Lekchiri Y., and Morcellet M. J. Appl. Polym. Sci. 97 (2005) 433
11. O'Brien T., and Collin J. Br. J. Surg. 79 (1992) 1262
12. O'Brien J., Wilson I., Orton T., and Pognan F. Eur. J. Biochem. 267 (2000) 5421
13. Puck T.T., and Marcus P.I. Proc. Natl. Acad. Sci. USA 41 (1955) 432
14. Til H.P., and Bär A. Reg. Toxicol. Pharm. 27 (1998) 159
15. Trochon V., Mabilat-Pragnon C., Bertrand P., Legrand Y., Soria J., Soria C., Delpech B., and Lu H. FEBS Lett. 418 (1997) 6